Evidence map›Paper›PMID 38836326›Full record

ArticleBioscience reports2024

Spatiotemporal regulation of the hepatocyte growth factor receptor MET activity by sorting nexins 1/2 in HCT116 colorectal cancer cells.

Laiyen Garcia Delgado, Amélie Derome, Samantha Longpré, Marilyne Giroux-Dansereau, Ghenwa Basbous, Christine Lavoie, Caroline Saucier, Jean-Bernard Denault

Abstract read
In one paragraph

Article in Bioscience reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Laiyen Garcia Delgado *Department of Pharmacology and Physiology.
Amélie Derome *Department of Pharmacology and Physiology.
Samantha LongpréDepartment of Pharmacology and Physiology.
Marilyne Giroux-DansereauDepartment of Pharmacology and Physiology.
Ghenwa BasbousUniversité de Sherbrooke's Cancer Research Institute (IRCUS), Université de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, QC J1H 5N4, Canada.
Christine LavoieDepartment of Pharmacology and Physiology.
Caroline SaucierUniversité de Sherbrooke's Cancer Research Institute (IRCUS), Université de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, QC J1H 5N4, Canada.
Jean-Bernard DenaultDepartment of Pharmacology and Physiology.ORCID 0000-0001-5392-0685

Funding

Canadian Institutes of Health Research (CIHR) 162354
6 · The paper itself

Abstract

Cumulative research findings support the idea that endocytic trafficking is crucial in regulating receptor signaling and associated diseases. Specifically, strong evidence points to the involvement of sorting nexins (SNXs), particularly SNX1 and SNX2, in the signaling and trafficking of the receptor tyrosine kinase (RTK) MET in colorectal cancer (CRC). Activation of hepatocyte growth factor (HGF) receptor MET is a key driver of CRC progression. In the present study, we utilized human HCT116 CRC cells with SNX1 and SNX2 genes knocked out to demonstrate that their absence leads to a delay in MET entering early endosomes. This delay results in increased phosphorylation of both MET and AKT upon HGF stimulation, while ERK1/2 (extracellular signal-regulated kinases 1 and 2) phosphorylation remains unaffected. Despite these changes, HGF-induced cell proliferation, scattering, and migration remain similar between the parental and the SNX1/2 knockout cells. However, in the absence of SNX1 and SNX2, these cells exhibit increased resistance to TRAIL-induced apoptosis. This research underscores the intricate relationship between intracellular trafficking, receptor signaling, and cellular responses and demonstrates for the first time that the modulation of MET trafficking by SNX1 and SNX2 is critical for receptor signaling that may exacerbate the disease.

Indexed as

Cell MovementCell ProliferationColorectal NeoplasmsHepatocyte Growth FactorProto-Oncogene Proteins c-metSorting NexinsEndosomesHCT116 CellsHumansPhosphorylationProtein TransportProto-Oncogene Proteins c-aktSignal TransductionHepatocyte Growth FactorHGF protein, humanMET protein, humanProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-metSNX1 protein, humanSNX2 protein, humanSorting NexinsColorectal cancerendosomal sortingHepatocyte growth factorMET receptorSorting nexin

Identifiers

PMID38836326
PMCPMC11196213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.